Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIMVASTATIN vs SITAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SIMVASTATIN vs SITAGLIPTIN: Safety Overview

Metric SIMVASTATIN SITAGLIPTIN
Total FAERS Reports 27,079 19,904
Deaths Reported 2,792 2,412
Death Rate 10.3% 12.1%
Hospitalizations 8,824 6,668
Average Patient Age 66.6 yrs 67.3 yrs
% Female Patients 47.5% 52.3%
FDA Approval Date Apr 14, 2009 Dec 30, 2025
Manufacturer Aphena Pharma Solutions - Tennessee, LLC A-S Medication Solutions
Route ORAL ORAL
Marketing Status Prescription Prescription